Aptevo Therapeutics Inc. — Director's Dealing 2019

Jul 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2019-07-10

Reporting Person: El-Hibri Fuad (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-10	Common Stock	P	18919	$0.8488	Acquired	843455	Direct

Footnotes

F1: The price reported represents the weighted average price of shares purchased in multiple transactions at prices ranging from $0.845 to $0.85 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.